Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancerJens R. Laurberg, Lars Dyrskjøt, Rainer Fietkau et al.|British Journal of Urology|2012Cited by 101
Chromosome 9 deletions are more frequent than <i>FGFR3</i> mutations in flat urothelial hyperplasias of the bladderJohanna M.M. van Oers, Arndt Hartmann, C. Adam et al.|International Journal of Cancer|2006Cited by 90
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, Laura S. Mertens et al.|European Urology|2020Cited by 89
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patientsLaura S. Mertens, Bas W.G. van Rhijn, Francesco Claps et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 39
FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancerRobert Stoehr, Arndt Hartmann, Johanna van Oers et al.|Cancer Research|2006Cited by 3